Your browser doesn't support javascript.
loading
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets.
Magalhães, Joana; Annunziato, Giannamaria; Franko, Nina; Pieroni, Marco; Campanini, Barbara; Bruno, Agostino; Costantino, Gabriele.
Afiliação
  • Magalhães J; Food and Drug Department , P4T group , Parco Area Delle Scienze 27/A - 43124 , Parma , Italy.
  • Annunziato G; Food and Drug Department , P4T group , Parco Area Delle Scienze 27/A - 43124 , Parma , Italy.
  • Franko N; Food and Drug Department , Laboratory of Biochemistry and Molecular Biology , Parco Area Delle Scienze 23/A - 43124 , Parma , Italy.
  • Pieroni M; Food and Drug Department , P4T group , Parco Area Delle Scienze 27/A - 43124 , Parma , Italy.
  • Campanini B; Food and Drug Department , Laboratory of Biochemistry and Molecular Biology , Parco Area Delle Scienze 23/A - 43124 , Parma , Italy.
  • Bruno A; Food and Drug Department , P4T group , Parco Area Delle Scienze 27/A - 43124 , Parma , Italy.
  • Costantino G; Experimental Therapeutics Program , IFOM-The FIRC Institute for Molecular Oncology Foundation , Via Adamello 16 - 20139 , Milano , Italy.
J Chem Inf Model ; 58(3): 710-723, 2018 03 26.
Article em En | MEDLINE | ID: mdl-29481752
Saturation transfer difference (STD) is an NMR technique conventionally applied in drug discovery to identify ligand moieties relevant for binding to protein cavities. This is important to direct medicinal chemistry efforts in small-molecule optimization processes. However, STD does not provide any structural details about the ligand-target complex under investigation. Herein, we report the application of a new integrated approach, which combines enhanced sampling methods with STD experiments, for the characterization of ligand-target complexes that are instrumental for drug design purposes. As an example, we have studied the interaction between StOASS-A, a potential antibacterial target, and an inhibitor previously reported. This approach allowed us to consider the ligand-target complex from a dynamic point of view, revealing the presence of an accessory subpocket which can be exploited to design novel StOASS-A inhibitors. As a proof of concept, a small library of derivatives was designed and evaluated in vitro, displaying the expected activity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Salmonella typhimurium / Cisteína Sintase / Inibidores Enzimáticos / Descoberta de Drogas Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Salmonella typhimurium / Cisteína Sintase / Inibidores Enzimáticos / Descoberta de Drogas Idioma: En Ano de publicação: 2018 Tipo de documento: Article